跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
吳 俊忠
教授
醫學生物技術暨檢驗學系
電話
0228267199 ext. 67283
電子郵件
jjwu1019
ym.edu
tw
h-index
h10-index
h5-index
11323
引文
58
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1860
引文
22
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
258
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1989 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(336)
類似的個人檔案
(6)
指紋
查看啟用 Jiunn-Jong Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Taiwan
100%
Helicobacter Pylori (H. pylori)
88%
Group A Streptococcus
56%
Escherichia Coli
51%
Klebsiella Pneumoniae (K. pneumoniae)
47%
Southern Taiwan
45%
Streptococcus Pyogenes (S. pyogenes)
39%
University Hospital
31%
Taiwanese
31%
Staphylococcal Enterotoxins
31%
Helicobacter Pylori Infection
27%
Antimicrobial Resistance
26%
Helicobacter Pylori Eradication
23%
Intensive Care Unit
23%
Integrated Microfluidic Device
21%
Triple Therapy
20%
β-lactamase
20%
Cefepime
18%
Non-susceptible
18%
Carbapenems
17%
Plasmid
17%
Extended-spectrum-lactamase
16%
Group B Streptococcus
16%
Bacteremia
15%
Metallo-β-lactamase
14%
Urinary Tract Infection
14%
Clinical Characteristics
14%
Enterobacteriaceae
14%
Enterobacter Cloacae
13%
Imipenem
13%
Endothelial Cells
12%
CMY-2
12%
Erythromycin
12%
Antimicrobial Susceptibility
12%
Rapid Detection
11%
Live Bacteria
11%
Pulsed-field Gel Electrophoresis
11%
Microbiological Characteristics
11%
Ertapenem
11%
Erythromycin Resistance
11%
Minimum Inhibitory Concentration
11%
Antibiotics
11%
Clinically Significant
10%
Group A Streptococcal Infection
10%
Virulence Factors
10%
Group A Streptococcus Infections
10%
Polymerase Chain Reaction
10%
Streptococcus Pneumoniae
10%
Pseudomonas Aeruginosa (P. aeruginosa)
9%
Induced Apoptosis
9%
Immunology and Microbiology
Pylorus
65%
Helicobacter Pylori
61%
Escherichia coli
54%
Streptococcus Group A
50%
Klebsiella pneumoniae
38%
Prevalence
30%
Antimicrobial Resistance
29%
Minimum Inhibitory Concentration
29%
Streptococcus pyogenes
29%
Exotoxin
28%
Plasmid
27%
Urinary Tract
25%
Mouse
22%
Virulence Factor
16%
Antibiotic Sensitivity
15%
Infectious Agent
14%
Wild Type
13%
Polymerase Chain Reaction
12%
Enterobacteriaceae
12%
Staphylococcus Aureus
11%
Pseudomonas aeruginosa
11%
Polymerase Chain Reaction
10%
Enterobacter Cloacae
10%
Serotype
10%
Salmonella
9%
Peritonitis
9%
Bacterial Virulence
9%
Promoter Region
8%
Mouse Model
8%
Type Strain
7%
Methicillin-Resistant Staphylococcus Aureus
7%
Streptococcus Agalactiae
7%
Outer Membrane
7%
Integrin
7%
Acinetobacter Baumannii
7%
Streptolysin
6%
Phagocytosis
6%
Flagellum
6%
Agar Dilution
6%
Loop-Mediated Isothermal Amplification
6%
Bacterium Detection
6%
Bactericidal Activity
6%
Peritoneal Dialysis
6%
Inflammation Response
6%
Western Blot
6%
Cloaca
5%
Monospecific Antibody
5%
Necrotizing Fasciitis
5%
Stomach
5%
CagA
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
36%
Helicobacter Pylori
33%
Penicillinase
32%
Escherichia coli
27%
Antimicrobial Resistance
27%
Klebsiella pneumoniae
25%
Prevalence
20%
Exotoxin
19%
Streptococcus Group A
19%
Antiinfective Agent
17%
Erythromycin
17%
Imipenem
15%
Infectious Agent
14%
Bacteremia
14%
Streptococcus pyogenes
14%
Disease
14%
Pseudomonas aeruginosa
14%
Enterobacteriaceae
12%
Carbapenem
12%
Macrolide
11%
Quinolone Derivative
11%
Cephalosporin Derivative
10%
Streptococcus Agalactiae
10%
Clarithromycin
10%
Extended Spectrum Beta Lactamase
10%
Salmonella
9%
Urea Breath Test
9%
Inosine Phosphate
9%
Minimum Inhibitory Concentration
9%
Penicillin Derivative
9%
Bloodstream Infection
9%
Urea C 13
9%
Enterobacter Cloacae
9%
Carbapenem Derivative
8%
Stomach Cancer
8%
Cefotaxime
8%
Periprosthetic Joint Infection
8%
Helicobacter Infection
8%
Levofloxacin
7%
Meningitis
7%
Urinary Tract Infection
7%
Quinolone
7%
Streptococcus
7%
Cephalosporin
7%
Ciprofloxacin
7%
Streptococcus Pneumoniae
7%
Agar Dilution
6%
Antibiotic Agent
6%
Intestine Metaplasia
6%
Group A Streptococcal Infection
6%
